- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.22 Å
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x FE: FE (III) ION(Non-covalent)
- 38 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 3 residues within 4Å:- Chain A: W.330
- Chain D: A.19, F.23
Ligand excluded by PLIPEDO.4: 1 residues within 4Å:- Chain A: Q.395
Ligand excluded by PLIPEDO.5: 9 residues within 4Å:- Chain A: R.87, E.90, T.91, Y.277, L.278, G.282, A.348, L.350
- Ligands: EDO.9
Ligand excluded by PLIPEDO.6: 2 residues within 4Å:- Chain A: D.510, K.514
Ligand excluded by PLIPEDO.8: 9 residues within 4Å:- Chain A: R.175, G.180, E.188, N.192, N.262, A.263, T.266
- Chain B: Q.74
- Ligands: EDO.11
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: V.94, Y.277, A.339, W.343, G.346
- Ligands: EDO.5
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain A: A.319, R.322, D.323
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: N.262, Q.445, E.449, R.452, Y.453
- Chain C: Y.147
- Ligands: EDO.8
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain A: Y.56, M.59, E.60, D.132, D.231, R.234
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: D.440, W.441, R.444
- Chain C: L.152
Ligand excluded by PLIPEDO.14: 2 residues within 4Å:- Chain B: S.307, E.308
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain A: F.68, L.72, F.142
- Chain B: E.48, W.105, H.107
- Chain H: K.95
- Ligands: EDO.16
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain B: W.105, H.107, P.108, K.111
- Chain F: R.118
- Ligands: EDO.15
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain B: P.41, R.42, R.97, Y.301
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: Y.139, A.340, K.341
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain C: R.3, I.11, D.48, I.49, D.50, V.51, D.52
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain C: V.25, D.26, L.72, T.82, G.84
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain B: R.9
- Chain D: K.42, A.71
- Chain E: R.77, L.78, G.79
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain E: V.477, R.478, S.479, G.481
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain B: D.364
- Chain E: L.3, K.4, V.5, R.7
- Chain F: R.134
Ligand excluded by PLIPEDO.28: 3 residues within 4Å:- Chain E: L.398, D.403, P.509
Ligand excluded by PLIPEDO.30: 6 residues within 4Å:- Chain A: R.66
- Chain E: E.65, F.68, L.72
- Chain F: H.107
- Ligands: EDO.37
Ligand excluded by PLIPEDO.31: 7 residues within 4Å:- Chain E: Y.277, A.339, W.343, G.346, A.348, L.350
- Ligands: EDO.33
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain E: K.284, F.285, K.286, E.356, D.357
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain E: V.94, F.98, L.169, G.346, F.347, A.348
- Ligands: EDO.31
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain B: F.123, Y.127, T.275
- Chain F: Q.266, P.278, A.282
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain A: P.9
- Chain B: A.125, A.126
- Chain F: Q.289, T.290
Ligand excluded by PLIPEDO.36: 5 residues within 4Å:- Chain B: Q.289, T.290
- Chain E: P.9
- Chain F: A.125, S.129
Ligand excluded by PLIPEDO.37: 6 residues within 4Å:- Chain D: K.95
- Chain E: F.68, F.142
- Chain F: E.48, H.107
- Ligands: EDO.30
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain F: Y.139, A.340, K.341, V.342, E.343
Ligand excluded by PLIPEDO.39: 4 residues within 4Å:- Chain F: A.229, T.230, E.233, S.327
Ligand excluded by PLIPEDO.40: 5 residues within 4Å:- Chain F: E.243, W.320, H.323, Y.324
- Chain G: I.78
Ligand excluded by PLIPEDO.41: 3 residues within 4Å:- Chain F: G.206, F.207, D.208
Ligand excluded by PLIPEDO.42: 2 residues within 4Å:- Chain F: P.14, E.15
Ligand excluded by PLIPEDO.43: 7 residues within 4Å:- Chain G: R.3, I.11, D.48, I.49, D.50, V.51, D.52
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain G: V.25, D.26, L.72, T.82, G.84
Ligand excluded by PLIPEDO.45: 4 residues within 4Å:- Chain E: F.430
- Chain G: Y.105, E.158, R.159
Ligand excluded by PLIPEDO.46: 5 residues within 4Å:- Chain A: R.77, G.79
- Chain F: R.9
- Chain H: K.42, A.71
Ligand excluded by PLIP- 2 x BEZ: BENZOIC ACID(Non-covalent)
BEZ.7: 13 residues within 4Å:- Chain A: L.99, E.103, A.106, E.133, F.177, F.181, L.193, G.197, E.198, T.202, E.232
- Ligands: FE.1, FE.2
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.99, A:F.177, A:F.177, A:F.181, A:L.193, A:E.198, A:T.202
BEZ.29: 13 residues within 4Å:- Chain E: L.99, E.103, A.106, E.133, F.177, F.181, L.193, G.197, E.198, T.202, E.232
- Ligands: FE.24, FE.25
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:L.99, E:F.177, E:F.177, E:F.181, E:L.193, E:E.198, E:T.202
- Salt bridges: E:H.235
- 2 x W6X: 1,1,1-tris(fluoranyl)propan-2-one(Covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jones, J.C. et al., Soluble Methane Monooxygenase Component Interactions Monitored by 19 F NMR. Biochemistry (2021)
- Release Date
- 2021-07-28
- Peptides
- Methane monooxygenase component A alpha chain: AE
Methane monooxygenase beta chain: BF
Methane monooxygenase gamma chain: CG
Methane monooxygenase regulatory protein B: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EB
BF
FC
CG
GD
DH
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.22 Å
- Oligo State
- hetero-2-2-2-2-mer
- Ligands
- 4 x FE: FE (III) ION(Non-covalent)
- 38 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x BEZ: BENZOIC ACID(Non-covalent)
- 2 x W6X: 1,1,1-tris(fluoranyl)propan-2-one(Covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jones, J.C. et al., Soluble Methane Monooxygenase Component Interactions Monitored by 19 F NMR. Biochemistry (2021)
- Release Date
- 2021-07-28
- Peptides
- Methane monooxygenase component A alpha chain: AE
Methane monooxygenase beta chain: BF
Methane monooxygenase gamma chain: CG
Methane monooxygenase regulatory protein B: DH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EB
BF
FC
CG
GD
DH
H